Regenerate Weight Loss
Slim180 Semaglutide Program
GLP-1 Weight Loss Injections
Medical weight loss with real guidance, accountability, and in-person care
Start online • In-office visit required for pricing & approval
What Is the Slim180 Semaglutide Program?
Slim180’s Semaglutide Weight Loss Program combines weekly GLP-1 injections with Slim180’s proven Nutritional Guidance Program to help reduce hunger, control cravings, and support sustainable weight loss.
This program is often compared to brand-name GLP-1 medications and uses compounded semaglutide when medically appropriate, paired with coaching and accountability for best results.
How It Helps
When combined with Slim180’s structured guidance, semaglutide may help:
-
Reduce appetite and food cravings
-
Increase feelings of fullness
-
Support blood sugar balance
-
Improve metabolic efficiency
-
Help the body burn stored fat more effectively
Slim180 focuses on long-term success, not quick fixes or medication alone.
What’s Included
-
Weekly semaglutide injections (as prescribed)
-
Slim180 Nutritional Guidance Program
-
One-on-one accountability and progress support
-
Ongoing medical supervision
Online Enrollment. In-Office Approval.
You may begin your journey online by requesting an appointment.
An in-office visit is required to:
-
Review medical history
-
Determine eligibility
-
Finalize personalized pricing
-
Receive physician approval and prescription
No medication is dispensed and no pricing is finalized without an in-office medical visit.
Who It’s For
Designed for adults who are overweight or obese and have struggled to lose weight through diet and exercise alone. Final eligibility is determined by a Slim180 medical provider.
Important Information
-
Prescription required
-
Results vary by individual
-
Not recommended for those who are pregnant, breastfeeding, or have certain medical conditions (reviewed during your visit)
*Purchasing this program through the online store only confirms your appointment; it does not guarantee a prescription or pricing details.
